Krishna Institute of Medical Sciences Limited

KIMS.NS·NSE·Healthcare
Compare
674.10−4.40 (−0.65%)today
At close: Oct 21, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close678.50
Open680.95
Day range661.30683.00
52-week range575.80858.00
Off day high−1.30%
Off 52-week high−21.43%
Volume377.46K
Avg. volume (3M)579.35K
Market cap283.13B
EPS (TTM)5.10
Forward P/E39.76
P/E ratio (TTM)132.18
Dividend yield—
Beta (5Y)0.27
Shares outstanding420.01M
Short interest—
Earnings dateAug 3, 2026 (est.)
Analyst target868.00
Profit margin4.85%

Against its peers

Compare in full ›
KIMS.NS MEDANTA.NS NH.BO MAXHEALTH.BO FORTIS.BO 5225.KL
Market cap 283.13B 331.17B 350.70B 798.11B 549.61B 70.16B
P/E (TTM) 132.2 59.6 41.5 55.0 52.4 31.8
Forward P/E 39.8 36.7 29.1 35.2 32.0 27.0
Price/book 12.0 8.4 8.6 7.4 5.6 2.2
Dividend yield — 0.04% 0.26% 0.24% 0.14% 1.39%
1-year change −5.79% −11.09% +28.30% −31.54% −29.88% −4.70%
Today −0.65% −0.46% −0.94% −1.12% −1.07% +0.38%

The closest companies by business and industry (Medical Care Facilities). Prices may be delayed up to 15 min.

Latest news

All KIMS.NS news ›
Moneycontrol·Positive

For KIMS Hospitals, home is where the growth is

The company announced strategic investments in four hospitals in existing business clusters For KIMS Hospitals, home is where the growth is The company announced strategic investments in four hospitals in existing business clusters…

VCCircle·

ChrysCap-backed KIMS buying into three healthcare firms

Krishna Institute of Medical Sciences Ltd (KIMS), backed by homegrown private-equity firm ChrysCapital, is set to buy significant stake in three healthcare assets that it has been operating so far. The acquisition comes after the…

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.